These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35702161)

  • 1. Early-Stage MRI Volumetric Differences in White Matter Hyperintensity and Temporal Lobe Volumes between Autopsy-Confirmed Alzheimer's Disease, Cerebral Small Vessel Disease, and Mixed Pathologies.
    Yang D; Masurkar A
    Dement Geriatr Cogn Dis Extra; 2022; 12(1):69-75. PubMed ID: 35702161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Profiles of Arteriolosclerosis and Alzheimer Disease at Mild Cognitive Impairment and Mild Dementia in a National Neuropathology Cohort.
    Yang D; Masurkar AV
    Alzheimer Dis Assoc Disord; 2021 Jan-Mar 01; 35(1):14-22. PubMed ID: 32925200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
    Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
    Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
    Kandiah N; Chander RJ; Ng A; Wen MC; Cenina AR; Assam PN
    Eur J Neurol; 2015 Jan; 22(1):150-5. PubMed ID: 25142829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
    Newton P; Tchounguen J; Pettigrew C; Lim C; Lin Z; Lu H; Moghekar A; Albert M; Soldan A;
    J Alzheimers Dis; 2023; 92(1):323-339. PubMed ID: 36744337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer's Dementia Using the NACC Database.
    Liu Y; Chan DK; Crawford JD; Sachdev PS; Braidy N
    Curr Alzheimer Res; 2020; 17(13):1167-1176. PubMed ID: 33583381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of regional white matter hyperintensities on specific gait function in Alzheimer's disease and mild cognitive impairment.
    Ogama N; Endo H; Satake S; Niida S; Arai H; Sakurai T
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2045-2055. PubMed ID: 34585518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.
    Gootjes L; Teipel SJ; Zebuhr Y; Schwarz R; Leinsinger G; Scheltens P; Möller HJ; Hampel H
    Dement Geriatr Cogn Disord; 2004; 18(2):180-8. PubMed ID: 15211074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
    Vipin A; Foo HJL; Lim JKW; Chander RJ; Yong TT; Ng ASL; Hameed S; Ting SKS; Zhou J; Kandiah N
    J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.
    Arfanakis K; Evia AM; Leurgans SE; Cardoso LFC; Kulkarni A; Alqam N; Lopes LF; Vieira D; Bennett DA; Schneider JA
    J Alzheimers Dis; 2020; 73(1):333-345. PubMed ID: 31771057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.
    Alosco ML; Sugarman MA; Besser LM; Tripodis Y; Martin B; Palmisano JN; Kowall NW; Au R; Mez J; DeCarli C; Stein TD; McKee AC; Killiany RJ; Stern RA
    J Alzheimers Dis; 2018; 63(4):1347-1360. PubMed ID: 29843242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presumed small vessel disease, imaging and cognition markers in the Alzheimer's Disease Neuroimaging Initiative.
    Fiford CM; Sudre CH; Young AL; Macdougall A; Nicholas J; Manning EN; Malone IB; Walsh P; Goodkin O; Pemberton HG; Barkhof F; Alexander DC; Cardoso MJ; Biessels GJ; Barnes J;
    Brain Commun; 2021; 3(4):fcab226. PubMed ID: 34661106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between white matter hyperintensity and delusional symptoms in Alzheimer's disease.
    Fan W; Ma S; Wang Z; Han Y; Liu X; Gu R; Cai Q
    BMC Psychiatry; 2023 Dec; 23(1):914. PubMed ID: 38057778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dementia is associated with medial temporal atrophy even after accounting for neuropathologies.
    Woodworth DC; Sheikh-Bahaei N; Scambray KA; Phelan MJ; Perez-Rosendahl M; Corrada MM; Kawas CH; Sajjadi SA;
    Brain Commun; 2022; 4(2):fcac052. PubMed ID: 35350552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease.
    Jang JW; Kim S; Na HY; Ahn S; Lee SJ; Kwak KH; Lee MA; Hsiung GY; Choi BS; Youn YC
    Eur Neurol; 2013; 69(4):229-35. PubMed ID: 23344183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Relationship of White Matter Hyperintensities with Depressive Symptoms and Daily Living Activities in Early-Stage Alzheimer's Disease Patients.
    Bilgiç B; Bayram A; Hanağasi HA; Tümaç A; Uysal P; Şentürk G; Alpsan H; Lohmann E; Gürvit H; Emre M
    Noro Psikiyatr Ars; 2013 Dec; 50(4):360-363. PubMed ID: 28360570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.